Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
PharmacoEconomics
Metadata
Title
The Economic Cost of Multiple Sclerosis in Sweden in 1994
Authors
Dr Freddie Henriksson
Bengt Jönsson
Publication date
01-05-1998
Publisher
Springer International Publishing
Published in
PharmacoEconomics / Issue 5/1998
Print ISSN: 1170-7690
Electronic ISSN: 1179-2027
DOI
https://doi.org/10.2165/00019053-199813050-00012

Other articles of this Issue 5/1998

PharmacoEconomics 5/1998 Go to the issue

Adis Pharmacoeconomic Drug Evaluation

Fluoxetine

Original Research Article

Economic Evaluation of Multiple Sclerosis in the UK, Germany and France

Original Research Article

Cost Effectiveness of Early Treatment with Oral Aciclovir in Adult Chickenpox

Leading Article

Should Antibacterials Be Deregulated?

Original Research Article

Cost Analysis of the Treatment of Schizophrenia in the UK

Original Research Article

Cost-Effectiveness Analysis of Treatments to Reduce Cholesterol Levels, Blood Pressure and Smoking for the Prevention of Coronary Heart Disease